Four distinct studies were carried out using two data sets of percutaneous epididymal sperm aspiration (PESA) and intracytoplasmic sperm injection (ICSI) procedures performed from March 1993 to January 1997. In study A, an analysis of 181 ICSI treatment cycles following PESA revealed a successful epididymal sperm retrieval rate of 83%. It confirmed that PESA is an effective sperm retrieval method and the associated ICSI pregnancy rate (35% per embryo transfer) compared favourably with that of other sperm retrieval methods. In study B, the relevance of a prior diagnostic PESA procedure was ascertained by comparing the sperm retrieval rates in two groups of patients having their first ICSI treatment cycle with spermatozoa retrieved through PESA. Group B1 (n = 50) had diagnostic PESA prior to the ICSI treatment cycle PESA procedure, unlike patients in group B2 (n = 64) who did not. The sperm retrieval rate in the treatment cycle procedure was not different at 90 and 82.8% for groups B1 and B2 respectively. However, the discontinuation of diagnostic PESA is fraught with problems including liability to medico-legal sanctions. In study C, analysis of 177 treatment cycles involving PESA and ICSI revealed a successful sperm retrieval rate by PESA of 82% in the first cycle, 93% in the second, 96% in the third and 100% in the fourth cycle. The same trend was evident when sperm retrieval was examined in relation to each of the epididymides. Retrieved spermatozoa were found to be motile in 67-100% of cases and the frequency of samples containing motile spermatozoa did not decrease with increase in the number of PESA attempts. These results show that PESA does not jeopardize future epididymal sperm retrieval. In study D, the outcome of treatment with ICSI using ejaculated spermatozoa (305 cycles) (group D1) was compared with that of ICSI using spermatozoa obtained through PESA (54 cycles) (group D2). The median age of women in the two groups of couples was similar (34 years). In group D1, 70% of metaphase II oocytes were fertilized compared with 61% in group D2 (P < 0.01). The cleavage rate and the median numbers of transferred and cryopreserved embryos were similar in both groups. There was no significant difference between the clinical pregnancy rates (33 and 42% in groups D1 and D2 respectively). Our results show that the outcome of PESA-ICSI treatment compares favourably with that of ICSI using ejaculated spermatozoa.
Introduction
The introduction of intracytoplasmic sperm injection (ICSI) into clinical practice has revolutionized the management of severe male factor infertility. Surgical sperm retrieval, in the form of microepididymal sperm aspiration (MESA) (Temple-Smith et al., 1985; Silber et al., 1990; Patrizio and Asch, 1992) , predated the clinical availability of ICSI but became more popular when ICSI proved to be a reliable method of achieving normal fertilization rates, even in the face of severe sperm abnormality. MESA requires the use of microsurgical equipment by specially trained uro-andrologists. Consequently, the availability of MESA has been limited to centres that can afford the expensive equipment and suitably trained personnel. Furthermore, the need for scrotal incisions means that there is always a chance of complications such as bleeding, haematoma formation, significant post-operative pain, infection and fibrosis following MESA. In view of these considerations a minimally invasive alternative to MESA, the percutaneous epididymal sperm aspiration (PESA) technique, was developed by personnel from our centres in Dubai and London, UK. Our earlier reports on the efficacy of this technique Shrivastav et al., 1994; Craft and Tsirigotis, 1995; Tsirigotis and Craft, 1995) and subsequent updates (Craft et al., 1995a; Meniru et al., 1996 Tsirigotis et al., 1996) have established PESA as a safe and effective method of surgical sperm retrieval. We have also developed a fine needle aspiration technique, for the retrieval of testicular tissue and spermatozoa using a similar percutaneous approach, which we termed testicular sperm aspiration (TESA) .
Our practice of PESA has evolved over time as more experience has been acquired in both the clinical and scientific aspects of the procedure and the use of surgically retrieved spermatozoa for ICSI. It is also now possible to address some areas of uncertainty because a larger sample population is now available. For example, during the development of PESA, a diagnostic procedure was deemed prudent in order to establish the feasibility of successful sperm retrieval by PESA in a subsequent ovulation induction cycle. Given the present large body of experience regarding this procedure and the generally high sperm retrieval rates (Craft et al., 1995a,b; Tsirigotis et al., 1996) the relevance of a diagnostic PESA procedure in contemporary practice may be questioned. Another example is the pattern of sperm retrieval during ICSI treatment cycles; there is at present no published information on this. Such information is even more important in relation to the second or subsequent treatment cycles, to establish whether a prior PESA procedure jeopardizes future sperm retrieval operations, although the necessity for multiple PESA procedures is decreasing because of the increasing availability of epididymal sperm cryopreservation techniques. Finally, one of the ways in which to establish how well a new treatment procedure is fulfilling expectations is to compare its performance with that of established methods. Thus ICSI with ejaculated spermatozoa, (which can be regarded as the 'gold standard'), is a suitable yardstick by which PESA-ICSI can be judged. Comparative analysis will establish the relative effectiveness of the PESA procedure and ascertain whether it exerts any deleterious effects on the quality of retrieved spermatozoa as indicated by poor fertilization rates after ICSI and subsequently poor treatment outcome. Due to differences in practice between different centres, it may be more relevant to compare the performance of these two groups of procedures within the same centre. We have analysed our cumulative experience to provide categorical information on the efficacy of PESA and to present current proposals for its conduct in routine clinical practice. This report is based on four different studies that were carried out using two data sets.
Materials and methods
This study covers the period 1 March, 1993 to 31 January, 1997, during which time 186 PESA procedures were initiated for the purpose of providing fresh sperm samples for ICSI treatment.
Strategy for sperm retrieval
Patient information and counselling prior to surgical sperm retrieval included items such as the novelty of PESA , the available information on its efficacy and all other aspects of the treatment. Following clinical evaluation and discussion of sperm retrieval techniques, a diagnostic PESA procedure was offered to the couples. The diagnostic step was especially important in cases where there was no previous history of spermatozoa being found in the ejaculate, e.g. congenital bilateral absence of the vas deferens (CBAVD). Patients with suspected testicular failure and other causes of non-obstructive azoospermia were also advised on the need for a TESA procedure to assess their chances of successful sperm recovery, since we believed that a substantial proportion of patients said to have secretory azoospermia actually poduce spermatozoa, but in extremely low concentrations. We have discovered that in-vitro maturation over 48-72 h often improves testicular sperm motility dramatically in such cases (Craft et al., 1995c; Zhu et al., 1996a,b) . In fact, significant improvement in motility may be found within 24 h of culture (G.I.Meniru, unpublished results). However, not all patients' spermatozoa will benefit from in-vitro maturation (Liu et al., 1996) and such individuals can be identified before hand with this diagnostic culture technique (Zhu et al., 1996b) . All couples were offered the option of having frozen donor spermatozoa provided for their use in case of failure to retrieve viable spermatozoa on the day of oocyte aspiration.
Ovulation induction
Multiple follicular development was stimulated with various dose regimens of follicle stimulating hormone (FSH) preparations and/or human menopausal gonadotrophin (HMG), usually using the long protocol of pituitary desensitization . Transvaginal oocyte aspiration, under intravenous sedation, was scheduled for 36 h after the administration of an ovulatory injection of human chorionic gonadotrophin (HCG). PESA was performed on the same day but prior to oocyte retrieval to ensure that viable spermatozoa from the husband were available for ICSI of the retrieved oocytes.
Anaesthesia for surgical sperm retrieval
Previously, most PESA procedures were carried out under general anaesthesia or i.v. sedation with Propofol (Diprivan; Zeneca Pharma, Wilmslow, UK) and Alfentanil (Rapifen; Janssen-Cilag Ltd, High Wycombe, UK). However, our policy has now changed to that of performing most PESA and/or TESA procedures under local, rather than general, anaesthesia unless the patient specifically requests general anaesthesia. About 10 ml of plain 1% lignocaine hydrochloride solution (Xylocaine; Astra Pharmaceuticals Ltd., Kings Langley, UK) is injected along the sides of each spermatic cord near the external inguinal ring. A recent audit by Gorgy et al. (1997a) revealed satisfactory analgesia in most cases and freedom from serious complications. Insufficient local analgesia is reinforced with i.v. sedation in a few cases.
Surgical sperm retrieval techniques
PESA was performed by stabilizing the epididymis between the index finger, thumb and forefinger while cupping the testis with the palm of the left hand, and pushing the tip of a 21 guage butterfly needle (Venisystems; Abbott Ireland Ltd, Sligo, Eire) through the stretched scrotal skin and into the substance of the epididymis. Negative pressure was created in the system by fully drawing back the plunger of an attached 20 ml syringe (B.Braun Melsungen AG, Melsungen, Germany). The tip of the needle was gently moved inwards and outwards within the epididymis until columns of slightly opalescent fluid were seen rising in the needle tubing Craft et al., 1995a; Tsirigotis and Craft, 1995) . The vacuum was maintained by applying a pair of artery forceps on the tubing near to the attached 20 ml syringe which was then removed and replaced with a tuberculin (1 ml) syringe (B.Braun Melsungen AG) containing gamete culture medium (IVF Medium; Medi-Cult, Copenhagen, Denmark). When a satisfactory aspirate volume was noted or no more aspirate was obtained, the needle was removed from the epididymis. The aspirate was then flushed into a sterile 1.5 ml Eppendorf tube (Becton Dickinson Ltd, Plymouth, UK) using the culture medium in the attached tuberculin syringe following release of the artery forceps clamping the end of the tubing. About 5 µl of this fluid in the Eppendorf tube was removed and smeared on a clean dry glass slide before being examined under the microscope to ascertain the presence of live motile spermatozoa. The PESA was repeated with fresh materials on that same epididymis and/or the opposite one until a satisfactory number of viable spermatozoa were deemed to have been recovered. It is not uncommon to recover sufficient spermatozoa for ICSI and cryopreservation with the first puncture and aspiration, the procedure lasting <10 min. The samples were maintained at 37°C while being transferred to the laboratory in a portable incubator (Henning Knudsen, Copenhagen, Denmark). The method for TESA was essentially similar; a larger (19) gauge butterfly needle (Venisystems) was passed into the testis and used for sampling different areas Zhu et al., 1996a) . 
Laboratory processing of PESA samples
The processing of PESA samples was carried out using different methods such as density gradient centrifugation, wash and swim-up, or washing alone, depending on the quality of the sample and observed sperm motility. Density gradient centrifugation was initially carried out with Percoll (Pharmacia LKB Biotechnology, Uppsala, Sweden) but we later changed to using PureSperm (NidaCon Laboratories AB, Gothenburg, Sweden) which was developed specifically for human use (Meniru and Hutchon, 1997 ). An aliquot of the PESA sample was gently layered over a discontinuous gradient of 0.3 ml of 45% PureSperm and 0.3 ml of 90% PureSperm and centrifuged at 500 g for 10 min. The pellet was resuspended in fresh gamete culture medium and centrifuged at 500 g for 10 min. The washing step was repeated with another aliquot of fresh culture medium. Density gradient centrifugation is no longer used as recovery of motile spermatozoa is unpredictable and often too low. We prefer simple washing and swim-up or washing alone. Sperm washing was performed by adding more culture medium to the PESA sample to make up the total volume of fluid in the Eppendorf tube to 1.5 ml. The sample was centrifuged in a Force 7 microcentrifuge (Denver Instrument Company, Denver, USA) at 600 g for 5 min. The pellet was resuspended in 1.5 ml of medium and spun again at 600 g for 5 min. Following this, the supernatant was carefully removed to leave ~0.3 ml of clear culture medium above the pellet and the tube placed for 30-60 min in an incubator maintained at 37°C in a 5% CO 2 /humidified air mixture. If no motile spermatozoa were recovered from the fluid above the pellet after this time, the pellet was resuspended in 0.3 ml of medium and used for ICSI as described in the following section.
Sperm retrieval from processed samples still containing debris
When the processed PESA sample was still contaminated by cellular debris, red blood cells and immotile spermatozoa, one of two techniques was used to avoid the injection of these contaminants along with the spermatozoa during ICSI. If the motile spermatozoa demonstrated progressive motility, 2 µl of the sample was carefully dropped at the centre of a 10 µl droplet of polyvinylpyrrolidone (PVP). Drops of HEPES-buffered medium were placed around the PVP droplets to hold the oocytes during injection. These drops were overlaid with equilibrated mineral oil. Following 30 min of incubation, motile spermatozoa would often have moved to the edge of the PVP droplet. Such spermatozoa were easily retrieved using the injection pipette for ICSI. When significant progressive motility was absent, three droplets of the sample were placed proximal to the PVP droplet while four droplets of HEPES-buffered culture medium were placed distally to the oocytes (Figure 1 ). The injection pipette was first placed in the PVP droplet to aspirate a small volume so as to improve the control during sperm retrieval from the sperm suspension droplet. Furthermore, the PVP column made it possible to eject the spermatozoa and cellular debris completely into the central PVP droplet without blowing air bubbles. After retrieving the spermatozoa from the PESA sample, they were washed free of any debris in the PVP droplet, and the tails scored with the injection pipette (Van den Bergh et al., 1995; Palermo et al., 1996) , followed by sperm aspiration and ICSI.
Fertilization, embryo culture and transfer
After at least 2 h of culture, the retrieved oocytes were denuded of their surrounding cumulus cells by a brief exposure to hyaluronidase solution (60-80 IU/ml) (Sigma Chemical Co, St Louis, MO, USA) and drawing them in and out of finely drawn sterile glass pipettes with an inner diameter of ~150 µm. Only metaphase II (MII) oocytes were retained and cultured in fresh culture medium until the time of injection. Following sperm retrieval, subsequent ICSI, assessment of fertilization and embryo culture were carried out using standard techniques. A maximum of three cleaving embryos was replaced in the uterus ~48 h after oocyte retrieval. Good quality supernumerary embryos were cryopreserved. The luteal phase was supplemented with natural progesterone pessaries.
Patients had a serum β-HCG pregnancy test 12 days after embryo transfer. Patients with positive test results continued using progesterone pessaries until 12 weeks of pregnancy; transvaginal ultrasound scans were performed 3 weeks after the positive pregnancy test to confirm clinical pregnancy and to determine whether there was multiple pregnancy.
Grading of embryo quality
Selection of embryos for transfer and cryopreservation was based on an assessment of their morphology and develop- Relevant data was extracted from the database of PESA-ICSI procedures described for study A. Specifically, information was obtained on the patient characteristics and outcome of attempted PESA in a first cycle of treatment with ICSI. Patients were divided into two groups based on whether they had had prior diagnostic PESA (group B1) or not (group B2). Data analysis was carried out using the SPSS package, the Mann-Whitney U-Wilcoxon rank sum W test and the test for equality of two population proportions (Dr J.Penzer; personal communication).
Study C: the efficacy of repeat PESA procedures
Information from the database was analysed to ascertain the pattern of sperm retrieval in relation to the number of previous attempts at PESA and PESA-ICSI.
Study D: PESA-ICSI compared with ICSI using ejaculated spermatozoa
The data utilized in this study were obtained from another computer database of assisted conception treatment procedures carried out at the London Gynaecology and Fertility Centre, UK, during the period January 1996 to January 1997. A total of 305 ICSI procedures were carried out using spermatozoa which had been retrieved from the ejaculate (group D1). Spermatozoa retrieved from successful PESA procedures were used in another 54 ovulation induction ICSI treatment cycles (group D2). Similar sperm preparation strategies were adopted for both PESA samples and semen, depending on the sperm concentration and extent of motility. Buoyant density gradient centrifugation, washing and swim-up or washing alone were carried out in respective cases when indicated (Fleming et al., 1997) . Data analysis was carried out using the SPSS package, the Mann-Whitney U-Wilcoxon rank sum W test and a test for the equality of two population proportions.
Results

Study A: Cumulative experience with PESA-ICSI
Of 186 treatment cycles in the database 181 cycles (135 patients) were found suitable for inclusion. Out of these 181 initiated treatment cycle PESA procedures, motile spermatozoa were successfully recovered by PESA in 151 cycles, while recovery of motile spermatozoa was only possible through MESA in two cycles, TESA in 11 cycles and testicular biopsy in eight cycles. Donor spermatozoa were used in six cycles where motile spermatozoa were not obtained despite using more than one sperm retrieval method; three more couples declined donor sperm utilization following failure to retrieve live spermatozoa. PESA was therefore successful in retrieving live motile spermatozoa suitable for ICSI in 83% of initiated cycles, and the account presented in this section is based on data derived from these 151 successful PESA cycles of treatment (113 patients).
The indications for surgical sperm retrieval included azoospermia resulting from CBAVD (55 cycles or 36.4%), failed reversal of vasectomy (57 cycles or 37.7%), irreversable vasectomy (six cycles or 4%), post-infective blockage of the vas deferens (six cycles or 4%), ejaculatory duct obstruction (three cycles or 2%) and vasal blockage in a man with the Kartagener's syndrome (0.7%). Other indications were anejaculation (four cycles or 2.6%), impotence unresponsive to conventional treatment (three cycles or 2%), secretory azoospermia (seven cycles or 4.6%), severe oligoasthenoteratozoospermia (two cycles or 1.3%), Young's syndrome (two cycles or 1.3%) and incomplete spermatogenic arrest (five cycles or 3.3%). All diagnoses, including those of non-obstructive azoospermia, had been made elsewhere, mainly by urologists, before these patients were referred to our centre. Both partners were offered screening for cystic fibrosis carrier status whenever a diagnosis of CBAVD was made.
Infertility was primary in 76% of females and 51% of males, while the secondary variety was found in 24% of females and 49% of males. The coexisting female problems were ovulatory dysfunction (mainly polycystic ovarian disease) (18%), tubal blockage (4%) and older age (1%). No apparent cause was found in 77% of women. The median age of the male and female partners was 42 years (range 20-65) and 33 years (range 20-46) respectively. The median duration of infertility was 3.5 years (range 1-17).
A total of 39 couples agreed to the provision of donor sperm backup, while others refused the offer on the grounds of religious belief or cultural factors (n = 32), or for personal reasons (n = 10). Furthermore, some patients had already acquired frozen PESA samples as backup (n = 12), or were optimistic based upon information obtained from the diagnostic PESA (n = 4). In all, 54 couples did not offer any reason for their refusal. Informed consent was given by all patients.
The various combinations of surgical sperm retrieval techniques used in 151 ICSI treatment cycles where PESA was successfully applied are shown in Table I . Many of the TESA procedures had been performed in the pioneering stages of simplified surgical sperm retrieval in this Centre. The objectives at that time were to provide histological assessment of spermatogenesis, especially in difficult cases. This was to find out whether the TESA sample would yield better quality spermatozoa and to provide a backup source of motile spermatozoa in cases where sperm viability and motility in the PESA sample was in doubt. TESA is now usually performed only in cases where non-viable or no spermatozoa are retrieved from the epididymis. A total of 87 patients (58%) did not have prior diagnostic PESA before the treatment cycle sperm retrieval (Table II) ; 42% of patients previously had diagnostic PESA; 41% of patients had ICSI treatment cycle PESA carried out at least once, and five patients had the procedure performed four times (Table II) .
A total of 1810 oocytes were retrieved, of which 1456 were at the MII stage. ICSI was subsequently carried out on these oocytes and 797 (55%) fertilized. The cleavage rate was 75% (596 embryos from 797 fertilized eggs) and 384 cleaving embryos were transferred. In 16 cycles, one embryo was replaced in each patient, while in 22 cycles, two embryos were replaced and in the remaining 108 cycles, three embryos were replaced. The median cumulative embryo score at the time of transfer was 12 (range 2-24). The number of treatment cycles reaching the stage of embryo transfer was 146. Failure of fertilization had occurred in four cycles, while in one other cycle, all the embryos were frozen. Clinical pregnancy was diagnosed in 51 couples while 90 other cycles were not successful. The outcome of treatment was unknown in five cycles. The clinical pregnancy rate per cycle was therefore 34% (51 out of 151) for cycles reaching the stage of oocyte retrieval and was 35% (51 out of 146) per embryo transfer. These values rose slightly to 35% (51 out of 146) and 36% (51 out of 141) per oocyte retrieval cycle and embryo transfer respectively if the five treatment cycles with unknown outcome were eliminated from the sample. Ultrasonography 3 weeks later demonstrated a single gestation sac in 40 patients, two sacs in six patients and three sacs in five patients thereby giving an implantation rate of 17.4% (67 sacs from 384 transferred embryos). Ten patients later miscarried, while 41 patients have delivered (Table III) . There were 29 singleton births, eight sets of twins, three sets of triplets and one set of quadruplets. One of the 25 male babies had trisomy 18, leading to neonatal death. Another male was diagnosed as having a malfunctioning kidney. All other babies were said to be normal. The trend in outcome of PESA-ICSI procedures performed at this centre is shown in Table IV . There has been a continued improvement in the outcome of PESA-ICSI treatment since results from the initial cycles were published. The records of 114 patients from study A who had their first ever PESA-ICSI treatment cycle were found to be complete and form the basis of the results. There were 50 patients in group B1 (prior diagnostic PESA) while the remaining 64 patients were in group B2 (no prior PESA). The median age of the patients in group B1 (41 years; range 23-65) was not significantly different from that of patients in group B2 (39 years; range 27-55). The median duration of infertility for patients in group B1 (4 years; range 1-15) also did not differ significantly from that in group B2 (4 years; range 1-14). The patients' reproductive history, type and cause of male factor associated infertility were similar (Tables V and VI) . Successful PESA was achieved in 90% of men who had a prior diagnostic procedure while the success rate appeared to fall slightly to 82.8% for those who did not have diagnostic PESA (Table VII) . This difference was not statistically significant. The number of patients who had TESA, testicular biopsy and MESA in the two groups of patients was too small for meaningful comparison. A review of the male factor problems in patients who had failed PESA showed no consistent difference in the distribution of those problems (Table VIII) .
Study C: the efficacy of repeat PESA procedures
Required information was complete on 177 cycles (134 patients) in the database in study A and they form the basis for the following results. The distribution of PESA and ICSI treatment cycles is shown in Table IX . Approximately 75% of cycles were first PESA-ICSI treatment cycles, while fewer were second (22%), third (5%) and fourth (1%) cycles. In 76 cycles the patients had had prior diagnostic PESA. When this was taken into consideration, the distribution of patients based on their total number of PESA cycles changed (Table IX) . Patients having their first ever PESA now constituted 44% of the patient population while those having their second PESA (including diagnostic PESA in some cases) made up 38%. It was interesting to note that 24 patients had up to three PESA procedures and seven patients each had four attempts (Table IX) . Successful sperm retrieval through PESA was achieved in 157 cycles (89%) (Table X) but TESA, MESA and testicular biopsy were required in 6, 1 and 4% of cycles respectively. Most of the failed PESA procedures were encountered in the first treatment cycle followed by the second cycle. By the third cycle only one failure occurred and TESA was performed in that case. All PESA pro- cedures were successful at the fourth attempt (Table X) . This trend in successful sperm retrieval by PESA is clearly evident in Figure 2 . The pattern of sperm retrieval from both epididymides through PESA is shown in Table XI . There was an increasing trend in successful sperm retrieval with increase in the index PESA cycle similar to the findings shown in Table X and Figure 2 . However, although sperm motility was demonstrated in a high proportion of cases, no definite trend was established as the number of PESA attempts increased (Table XI) .
Study D: PESA-ICSI compared with ICSI using ejaculated spermatozoa
The median age of women in couples who had ICSI with ejaculated spermatozoa (group D1) was 34 years (range 18-47). This was not significantly different from that of 34 years (range 21-46) found in couples who had PESA and ICSI (group D2). Out of 3440 retrieved oocytes in group D1, 2813 MII oocytes (82%) were injected and 1966 (70%) fertilized; 1818 (92%) fertilized eggs subsequently cleaved into embryos. For group D2, out of 585 retrieved oocytes, 492 (84%) were injected and 298 (61%) fertilized; the cleavage rate was 91% (271 out of 298 fertilized eggs). The fertilization rate of 70% found in group D1 was significantly higher than the rate of 61% found in group D2 (P < 0.01). The number of cycles reaching embryo transfer stage was 297 (97%) for group D1 and 53 (98%) for group D2. Transfer of a total of 816 embryos was performed in group D1 while 138 were transferred in group D2. Other summary statistics are shown in Table XII . There was no significant difference between the embryological parameters in the two groups. The median number of fertilized and cleaved eggs appeared to be higher in group D1, when compared with group D2, but this difference was not statistically significant.
The outcome of treatment is shown in Table XIII . Positive pregnancy test results were obtained in 101 females in group D1 and 23 in group D2. Following adjustment of the figures because of biochemical pregnancies and a case of blighted ovum, the clinical pregnancy rate per embryo transfer was 33% for group D1 (98 pregnancies from 297 embryo transfer cycles) and 42% for group D2 (22 pregnancies from 53 embryo transfer cycles). The pregnancy rates were not significantly different. The implantation rate of 11.7% for group D1 (96 gestation sacs from 816 transferred embryos) was not significantly lower than the rate of 13.8% found in group D2 (19 gestation sacs from 138 transferred embryos). (71) 107 (85) a No. of patients in whom sperm retrieval was successful on that specific side. b No. of patients in whom sperm motility was demonstrated on that specific side. 
Discussion Study A: cumulative experience with PESA-ICSI
It is quite clear from the results of this study that PESA is an effective surgical sperm retrieval method. The successful retrieval of live motile spermatozoa of sufficient quality to be used for ICSI occurred in 83% of initiated cycles. Silber et al. (1995a) reported a failure rate of 42.8% for MESA. The so-called PESA failures in our study were not necessarily technical failures since in many of the samples, spermatozoa were found but they were either non-viable or immotile. Even if motile spermatozoa were seen occasionally, the spermatozoa retrieved with the other methods were judged to be of better quality and were used for ICSI. Some cases with PESA failure also had experienced sperm retrieval with the other methods. We have already documented a successful ICSI treatment cycle PESA rate in the range of 80-100% (Craft et al., 1995a,b) , but the larger sample size of the present study together with the adoption of strict criteria for definition of successful sperm retrieval in treatment cycles, provide stronger evidence to support the efficacy of PESA. In view of our findings, we believe that PESA successfully samples fluid secretions in the epididymis in most instances. Failure to obtain viable spermatozoa through PESA should no longer be regarded as being due to an intrinsic defect of the technique, but to inexperience or absence of adequate spermatogenesis in the testes as detectable in the epididymides. In rare instances, the possibility of a pre-epididymal block should also be considered. Furthermore, the development of TESA as a minimally invasive method of obtaining testicular material Khalifa and Grudzinskas, 1996) means that there is a backup measure that can be applied successfully to cases where PESA fails, but where there is spermatogenesis in the testes. It should be noted that MESA is not invariably successful in epididymal sperm retrieval particularly in cases with previous surgery. Madgar et al. (1996) reported that MESA failed to retrieve spermatozooa in 12 out of 53 patients (23%), necessitating testicular biopsy. PESA does not depend on visualization of epididymal tubules; rather a needle is directed into a palpable part of the epididymis using well established surgical principles of fine needle aspiration for cytology. It follows that scarring from previous surgery will not prevent needle access to any epididymal tubules that are still patent.
In the early period of the development of the PESA and TESA techniques, it became obvious to us that conventional methods of sperm preparation could not be relied upon to extract the relatively small number of spermatozoa from such cases. It is known that the return of spermatozoa during density gradient centrifugation, for example, is relatively low but the number of recovered spermatozoa is usually high enough for conventional in-vitro fertilization (IVF), ICSI or intrauterine insemination if the original sample (semen) has a normal concentration of spermatozoa, which is usually in the order of several millions. The ability of media used in such sperm preparation methods to allow passage of only normal motile spermatozoa during centrifugation, leading to preparation of a clean sperm suspension that is free of cellular debris, has established a prominent place for their use in the preparation of semen samples. We have adapted to the relatively low sperm numbers in PESA and TESA samples by working with small volumes of culture media, only washing the sample once before swim-up when there are progressively motile spermatozoa, or retrieving spermatozoa directly from the resuspended pellet for ICSI. Currently, we do not use gradient media centrifugation for PESA or TESA samples.
Although some degree of contamination of PESA samples by red blood cells is invariable, heavy contamination of clinical samples is uncommon and may be reduced by the addition of a swim-up phase to the sperm preparation if progressive motility is adequate. Alternatively, the ICSI needle can be used in a sweeping motion to move the red blood cells away from the spermatozoa before aspiration. While it is desirable to work with sperm preparations that are free of debris, our experience to date shows that operator speed does not drop substantially during ICSI in the few instances when there is appreciable contamination with red blood cells. Furthermore, in our experience, the fertiliz-ation and pregnancy rates are not lower, contrary to the views expressed by Schlegel et al. (1995) .
Our fertilization rate of 55% for PESA compares favourably with rates of 34.4, 40.6 and 55.9% reported by Madgar et al. (1996) , Silber et al. (1994) and Tournaye et al. (1994) respectively, following ICSI with spermatozoa obtained through MESA. It also marks a further improvement in rates obtained during the earlier years of the use of PESA in our Centre. In fact, successive reports have shown a continued improvement in fertilization rates and other measures of outcome (Table IV) . Our fertilization rate is, however, <65% (201 two pronuclear oocytes per 309 injected MII oocytes) reported by Cha et al. (1997) for ICSI with freshly recovered spermatozoa through MESA. These same workers also carried out epididymal sperm recovery using what they called a modified PESA technique; subsequent ICSI with retrieved spermatozoa resulted in a 69% (527/759) fertilization rate. It is accepted that although epididymal and testicular spermatozoa are somewhat physiologically immature they are able to fertilize oocytes when used for ICSI (Craft et al., 1993) and produce normal progeny similar to other assisted conception treatments. Previous reports have not found any significant association between sperm parameters of PESA samples and fertilization or pregnancy rates (Craft et al. 1995b; Tsirigotis et al. 1996) . It will be interesting to see whether there will be any further increases in the pregnancy rates in this group of couples because, theoretically, women here should have a lower incidence of female factor problems that may otherwise decrease the chances of pregnancy. Eliminating the male factor problem by ICSI should lead to optimal pregnancy rates. The embryo quality and developmental stage at the time of transfer were satisfactory (median cumulative embryo score = 12; range 2-24) but the implications of an associated female factor infertility problem in 23% of our sample are not clear at present.
The focus of our approach to PESA has been that of developing a reliable technique which will supply spermatozoa from the epididymis any time spermatozoa is required for ICSI. Thus our study shows that about 60% of our patients have had at least a second successful sperm retrieval with five men having had it four times (Table II) . Therefore, PESA does not seem to jeopardize future epididymal sperm retrieval operations, unlike the experience of Madgar et al. (1996) seems to suggest for MESA. We have examined this finding further in study C. Unfortunately, success at assisted conception treatment cannot be ensured at any particular cycle of treatment and there is always a chance that a couple may need more than one cycle to become pregnant. We have begun evaluating various cryopreservation protocols to enable us to store spermatozoa for future cycles of treatment. Our preliminary findings show that a precisely controlled freezing rate using a Kryo 10 programmable freezer (Planer Products Ltd, Sunbury, UK) achieved better results than suspending the sample in liquid nitrogen vapour (unpublished results). Furthermore, we have been able to freeze several straws of spermatozoa from one episode of PESA by applying the same principle of working with small numbers of spermatozoa. On thawing a straw, the sample is washed with a small amount of culture medium and concentrated into a 20 µl drop that is overlaid with liquid paraffin and spermatozoa are retrieved directly from the droplet using micropipettes. The results of this study suggest that diagnostic PESA does not confer much of an advantage to the patient in terms of successful sperm retrieval during the crucial ICSI treatment cycle repeat PESA procedure. Although the proportion of patients who had a successful treatment cycle PESA was higher when they had a diagnostic PESA (90%), this was not significantly greater than the 82.8% retrieval rate found in those who did not have the diagnostic procedure. The reasons for this are not immediately clear. It is logical that a diagnostic PESA should enable selection of patients with a greater chance of successful sperm retrieval in subsequent PESA carried out for ICSI, unlike the largely unscreened population of patients who did not have diagnostic PESA. However, it may be that some element of screening took place in the second group of patients before the commitment to a first ever PESA procedure within the context of an ICSI treatment cycle. Thus men with azoospermia and raised plasma FSH concentration may have been offered TESA or testicular biopsy rather than an attempt at PESA, unlike in the case of obstructive azoospermia. Similarly, men with failed reversal of vasectomy or CBAVD, where testicular failure is not a common feature, may have elected to have a treatment cycle PESA procedure only. Our results did not show a predominance of a particular male factor problem in any of the groups. Comparison of the study population characteristics also showed a largely similar distribution of the patients' age, parity and duration of infertility. It seems, therefore, that whatever advantage that might have been conferred by a successful previous diagnostic PESA was not strong enough to show a statistically significant difference in the treatment cycle surgical sperm retrieval rates of the two groups. Furthermore, the generally high efficacy of PESA may make any difference in the sperm retrieval rates between screened and unscreened patients difficult to detect.
These results also show that a previous PESA procedure does not necessarily jeopardize a subsequent sperm retrieval procedure. The sperm retrieval rate in men who had a previous (diagnostic) PESA was 90%. We are not aware of any report on MESA that has shown a similarly successful repeat sperm retrieval rate and this highlights one of the long-term benefits of the less invasive PESA procedure. PESA does not seem to cause epididymal scarring, or at least not severe enough to impede future epididymal sperm retrieval. We reviewed sperm retrieval in a larger patient population (study C) and found that PESA is even successful up to the fourth attempt.
Diagnostic PESA was an early feature in the development of surgical sperm retrieval at our Centre and was emphasized because of the lack of information on the efficacy and reliability of the technique. In addition, there were no data on the sperm retrieval rate for the various classes of male factor problems found in the patient population. It was, therefore, more sensible and humane to perform a diagnostic PESA to assess sperm recovery before the definitive treatment cycle procedure. An additional factor was the then lack of experience in cryopreservation of epididymal and testicular spermatozoa; initial post-thaw and viability results were often poor and unpredictable. There have now been several reports of successful utilization of thawed frozen epididymal and testicular spermatozoa for ICSI (Devroey et al., 1995; Nagy et al., 1995 ; Patrizio et al., 1995; Edirisinghe et al., 1996; Fischer et al., 1996; Gil-Salom et al., 1996; Hovatta et al., 1996; Oates et al., 1996; Podsiadly et al., 1996; Friedler et al., 1997; Khalifeh et al., 1997) . Cryopreservation of epididymal and testicular spermatozoa has become a viable component of the strategy for surgical sperm retrieval and ICSI.
The prudence behind a diagnostic PESA procedure is not in doubt and may be a more important consideration when each patient is considered individually. Medico-legal reasons may dictate the need for diagnostic PESA before committing resources to ovulation induction treatment and planning for ICSI. Recent changes in our surgical sperm retrieval strategy have therefore not eliminated the offer of diagnostic PESA to patients following clinical evaluation. Rather we are now evaluating cryopreservation of retrieved spermatozoa for potential use in the first or subsequent ICSI treatment cycles. The PESA sample is mixed with an equal volume of a glycerol-based cryoprotectant medium, loaded into straws and frozen in a programmable freezer. This may make a repeat PESA unnecessary. In this way a successful diagnostic PESA becomes a potential source of viable spermatozoa to be used for ICSI in subsequent treatment cycles as well as confirming the feasibility of surgical sperm retrieval for that particular patient.
Study C: the efficacy of repeat PESA procedures
This study shows that the efficacy of PESA does not diminish in subsequent attempts. Rather, there is a higher chance of successful sperm retrieval in patients who need repeat PESA procedures to supply spermatozoa for further ICSI cycles. Thus 82% (64 out of 78) of first treatment cycle PESA attempts were successful (Table II) with this figure rising to 93, 96 and 100% in the second, third and fourth treatment cycles respectively. This finding is also in accordance with our previously unpublished observations on the efficacy of PESA in patients who have had previous PESA procedures at our centre. There is a chance that some element of bias may be present in the study population. For example, men who have had a previous failed attempt at PESA may not come for a first or subsequent ICSI treatment cycle PESA procedure. This is, however, not relevant to this study which was designed simply to ascertain the overall chances of successful sperm retrieval by PESA in the first and subsequent attempts made in an unselected clinic patient population the partners of whom were having ovulation induction and ICSI treatment cycles. Furthermore, the experience from repeat MESA cycles suggests that scarring from a previous retrieval procedure jeopardizes subsequent attempts (Madger et al., 1996; Khalifeh et al., 1997) . The fact that this was not encountered in our patient population is highly suggestive of minimal or complete absence of post-operative fibrosis of the epididymis following PESA. This is not surprising given the minimally invasive nature of PESA in comparison to MESA (Khalifa and Grudzinskas, 1996) . Similar considerations were pivotal to the change of preference from laparotomy to laparoscopy for the surgical management of amenable gynaecological pathology. Even if PESA causes epididymal fibrosis, the extent is probably not severe enough to interfere with repeat epididymal aspiration. Finally, we have documented a low incidence of post-operative morbidity in our patients (Gorgy et al., 1997b) .
For many years, conventional IVF remained the only method for achieving extracorporeal fertilization during clinical management of infertility. Although some couples with certain classes of male factor-associated infertility were successfully treated with this insemination method, others proved refractory to treatment and manifested either poor fertilization rates or complete absence of fertilization. A serious limitation of conventional IVF is the requirement for insemination by several thousand spermatozoa or more.
With the advent of ICSI, fertilization of retrieved oocytes and subsequent establishment of pregnancy have become possible in situations where only a small number of spermatozoa can be retrieved from the ejaculate or directly from the male reproductive tract. Unfortunately, the present success rate of assisted conception treatment generally is such that pregnancy cannot be guaranteed in the first or any specific cycle of treatment. This means that epididymal sperm aspiration may have to be repeated in a subsequent treatment cycle if there is poor or non-survival of cryopreserved epididymal spermatozoa, or no sample at all was cryopreserved. This underscores the need for a sperm retrieval method that is simple, associated with few side-effects and can be repeated without fear of jeopardizing future retrieval operations or even ejaculation in rare cases of restoration of potency or ejaculatory function in a select group of patients (unpublished report). Another desired quality is that post-operative discomfort and disruption of the patients' routine should be minimal. The effect on the patient should also be such that he is favourably disposed to having a repeat procedure in future if need be, although attempts should always be made to cryostore spermatozoa for possible use in future. Our cumulative experience of PESA as shown by the results of this study indicate that there should be little or no fear of failed sperm retrieval if repeat PESA becomes necessary in future.
Study D: PESA-ICSI compared with ICSI using ejaculated spermatozoa
The results of this study indicate that treatment outcome following ICSI with spermatozoa that are recovered percutaneously from the epididymis compares favourably with that of ICSI using ejaculated spermatozoa. The clinical pregnancy rate of 42% after PESA-ICSI was not significantly different from that of 33% found in cases of ICSI with ejaculated spermatozoa. This was in spite of a significantly lower fertilization rate of 61% following ICSI in the group of patients who had PESA when compared to that of 70% found in the other group (P < 0.01). Following fertilization the cleavage rates became similar (group D1 = 92%; group D2 = 91%) and the same proportion of patients reached the stage of embryo transfer (group D1 = 97%; group D2 = 98%). There was also no statistically significant difference in the median number of transferred and cryopreserved embryos. The 1996/1997 PESA-ICSI fertilization rates (i.e. study D) and indeed most other outcome parameters, were better than the overall rates found in the overall database described in study A (March 1, 1993 to January 31, 1997 . This is as a result of greater experience with PESA and ICSI at our centre in later years compared with earlier years. We did not find the favourable results surprising, having noted similar trends during our in-house treatment result reviews. There is also support for our results in the scientific literature, albeit indirectly, as discussed below.
An important attribute of ICSI, and one that is well accepted, is the fact that it ensures reasonably satisfactory and predictable fertilization and pregnancy rates. This is irrespective of the sperm parameters of the patients (Oehninger and Kruger, 1995; Seibel and Zilberstein, 1995; Svalander et al., 1996) provided that the injected spermatozoa are viable. Additionally, it has been well documented that outcome of ICSI treatments with either epididymal or testicular spermatozoa are broadly similar (Silber et al., 1995a,b; Kahraman et al., 1996) , but that fertilization rates are generally lower than those obtained following ICSI with ejaculated spermatozoa (Palermo et al., 1996) ; this is similar to the findings of our study. Aboulghar et al. (1997) did not find any significant difference between treatment results following ICSI with ejaculated spermatozoa and with epididymal spermatozoa. The fertilization and pregnancy rates were 56.9 and 34.3% respectively for ICSI with ejaculated spermatozoa and 55.1 and 36.4% with epididymal spermatozoa. It appears that some patients had MESA while others had PESA in that study.
Contamination of PESA samples by blood is not uncommon but the incidence is probably <25% in our experience and is seldom heavy. While we initially found this disconcerting we have been able to eliminate much of the red blood cells by incorporating a swim-up phase during processing of the sample when motility of retrieved spermatozoa is adequate. Alternatively, ~2 µl of the PESA sample can be placed at the centre of a flattened 10 µl droplet of PVP and incubated under liquid paraffin for 30 min. This often results in spermatozoa migrating away from the debris and to the edge of the droplet where they can be easily retrieved with the injection needle and used for ICSI. Even when it is impossible to separate feebly motile spermatozoa from surrounding debris during sperm preparation procedures, we have found that the microinjection procedure time is not increased excessively; in such cases, motile spermatozoa are first of all retrieved from the debris and washed clean in PVP before injection. In other words, we have not found contamination of PESA samples by blood to be an impediment to the execution of the microinjection procedure and the results of this study show that it also does not affect the outcome of treatment.
Ours and, we believe, most other workers' experience with processing testicular tissue for the retrieval of spermatozoa shows that there is a greater degree of contamination of samples by blood. Yet a large number of reports have demonstrated the efficacy of ICSI with testicular spermatozoa and many practitioners routinely perform TESA or TESE. Verheyen et al. (1995) used a haemolysing buffer during their evaluation of methods of sperm extraction from testicular tissue. They have now reported their preliminary clinical experience of using this haemolysing buffer during ICSI treatment cycles (Nagy et al., 1997) . This buffer can be used for the lysis of red blood cells in occasional situations of heavy contamination of PESA samples with blood. This will obviously make sperm retrieval for ICSI easier, but it is not clear if it will have a demonstrable effect on the fertilization rate and subsequent outcome of the treatment.
The pregnancy rate was not significantly different in couples who had PESA-ICSI when compared to others. This similarity in pregnancy rates occurred despite a lower fertilization rate after PESA-ICSI. One possibility is that whatever factor (most probably spermatozoal) was responsible for the difference in fertilization rates soon ceased operating or was overwhelmed by the effect of other factors. Thus cleavage rates were similar in the two groups of patients and the median number of transferred and cryopreserved embryos was the same. Female factors, such as age, have been shown to exert substantial influence on the success of ICSI treatment (Silber et al., 1995b; Devroey et al., 1996) . The two groups of females in this study were similarly aged thereby negating the influence of age in this particular study. Still, this does not completely exclude female factor problems from being operational here. It is a truism that the more severe a male factor problem is, the less likely there is to be a coexisting female problem in that cohort of couples. This is as a result of selection pressure which tends to remove fertile, problem-free females from the group because they are usually able to compensate for mild to moderate degrees of male subfertility and fall pregnant within a reasonable period of time. Therefore, women in the group that had PESA-ICSI should have at least a similar chance of becoming pregnant as women in the group where ejaculated spermatozoa were injected.
In conclusion, long-term evaluation of any new treatment technique either provides reassuring information regarding its safety and efficacy or turns up evidence leading to abandonment of the technique. Recent experience with PESA has continued to show that it is a safe and effective surgical sperm retrieval method. There is now a greater understanding of its potentials and we have explored further applications of the procedure. We have shown that PESA-ICSI compares favourably with ICSI using ejaculated spermatozoa.
